Literature DB >> 3365032

Polymyositis after propylthiouracil treatment for hyperthyroidism.

W J Shergy1, D S Caldwell.   

Abstract

An additional disorder in the spectrum of thyroid related muscle disease is presented. Hypothyroid and hyperthyroid disease are both associated with a variety of muscle abnormalities, from myalgias to myopathy. Polymyositis, however, has never been reported immediately after treatment for active hyperthyroidism. A patient is presented with typical hyperthyroidism, who developed a severe proximal muscle weakness and a raised creatine phosphokinase after treatment for hyperthyroidism with propylthiouracil (100 mg orally, three times a day). Electromyography, muscle biopsy, and the course of the patient's illness were consistent with polymyositis. Whether this represents a cause-effect association or a chance occurrence is unknown. Physician awareness of the occurrence of a variety of muscle disorders including polymyositis in thyroid disease is emphasised. A brief discussion of thyroid myopathy, thionamide drug reactions, and polymyositis is included.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3365032      PMCID: PMC1003518          DOI: 10.1136/ard.47.4.340

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  17 in total

Review 1.  Polymyositis and dermatomyositis (first of two parts).

Authors:  A Bohan; J B Peter
Journal:  N Engl J Med       Date:  1975-02-13       Impact factor: 91.245

2.  Prognosis in adult polymyositis.

Authors:  D Riddoch; J A Morgan-Hughes
Journal:  J Neurol Sci       Date:  1975-09       Impact factor: 3.181

3.  A "collagen-like" syndrome associated with antithyroid therapy.

Authors:  W Hung; G P August
Journal:  J Pediatr       Date:  1973-05       Impact factor: 4.406

4.  Arthritis induced by antithyroid medication.

Authors:  K Farbman; M F Wheeler; S M Glick
Journal:  N Y State J Med       Date:  1969-03-15

5.  Polymyositis and dermatomyositis: combined methotrexate and corticosteroid therapy.

Authors:  A L Metzger; A Bohan; L S Goldberg; R Bluestone; C M Pearson
Journal:  Ann Intern Med       Date:  1974-08       Impact factor: 25.391

Review 6.  Thyrotoxic muscle disease.

Authors:  I Ramsay
Journal:  Postgrad Med J       Date:  1968-05       Impact factor: 2.401

7.  Agranulocytosis and antithyroid drugs.

Authors:  M H Rosove
Journal:  West J Med       Date:  1977-05

8.  Polymyositis: its presentation, morbidity and mortality.

Authors:  R DeVere; W G Bradley
Journal:  Brain       Date:  1975-12       Impact factor: 13.501

9.  Rhabdomyolysis in thyroid storm.

Authors:  W R Bennett; D P Huston
Journal:  Am J Med       Date:  1984-10       Impact factor: 4.965

10.  Antithyroid drug therapy for toxic diffuse goiter (Graves disease): thirty years experience in children and adolescents.

Authors:  H V Barnes; R M Blizzard
Journal:  J Pediatr       Date:  1977-08       Impact factor: 4.406

View more
  4 in total

1.  Antithyroid arthritis syndrome.

Authors:  Anar Modi; Hari Amin; Farah Morgan
Journal:  BMJ Case Rep       Date:  2017-02-27

Review 2.  Polymyositis associated with hypothyroidism or hyperthyroidism: two cases and review of the literature.

Authors:  Han Wang; Hong Li; Cui Kai; Juelin Deng
Journal:  Clin Rheumatol       Date:  2010-09-21       Impact factor: 2.980

3.  Methimazole-induced myositis: a case report and review of the literature.

Authors:  R Bou Khalil; M Abou Salbi; S Sissi; N El Kara; E Azar; M Khoury; G Abdallah; J Hreiki; S Farhat
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2013-08-30

4.  Anti-thyroid drugs-related myopathy: is carbimazole the real culprit?

Authors:  Chiu Chi Tsang; Wai Shan Hui; Kwun Man Lo; Jonas Hon Ming Yeung; Yuk Lun Cheng
Journal:  Int J Endocrinol Metab       Date:  2015-01-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.